Work

Abstract PS1-12-08: Real-world ESR1 mutation (ESR1m) testing and positivity rates in patients with ER+, HER2- metastatic breast cancer (MBC)

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-12-08

Authors: C. Liao, N. Bansal, J. John, M. Bhave, F. Bidard, T. Marquart, A. Chawla, L. Williams

Institutions: Eli Lilly (United States), Emory University, Winship Cancer Institute, Institut Curie

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129577198

Cites:

Cited by:

Related to: